Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
September 20, 2019 | 10.4244/EIJ-D-19-00325
Showing 1-10 of 10 articles
Coronary interventions
Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score May 7, 2019 | 10.4244/EIJ-D-18-00884
Coronary interventions
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial) December 7, 2018 | 10.4244/EIJ-D-18-00839
Coronary interventions
Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging August 5, 2016 | 10.4244/EIJV12I5A97
Coronary interventions
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study July 20, 2016 | 10.4244/EIJY15M08_03
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
July 20, 2015 | 10.4244/EIJV11I3A53
Tools and Techniques - Clinical: the transaortic approach through a mini-sternotomy using the self-expandable CoreValve Revalving System
September 27, 2013 | 10.4244/EIJV9I5A103